A citation-based method for searching scientific literature

Eric S Kilpatrick, Alan S Rigby, Stephen L Atkin. Diabetes Care 2009
Times Cited: 94







List of co-cited articles
485 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes.
Louis Monnier, Emilie Mas, Christine Ginet, Françoise Michel, Laetitia Villon, Jean-Paul Cristol, Claude Colette. JAMA 2006
47

The effect of glucose variability on the risk of microvascular complications in type 1 diabetes.
Eric S Kilpatrick, Alan S Rigby, Stephen L Atkin. Diabetes Care 2006
230
40



Glucose variability does not contribute to the development of peripheral and autonomic neuropathy in type 1 diabetes: data from the DCCT.
S E Siegelaar, E S Kilpatrick, A S Rigby, S L Atkin, J B L Hoekstra, J H Devries. Diabetologia 2009
48
54

Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients.
Antonio Ceriello, Katherine Esposito, Ludovica Piconi, Michael A Ihnat, Jessica E Thorpe, Roberto Testa, Massimo Boemi, Dario Giugliano. Diabetes 2008
693
25

Mean amplitude of glycemic excursions, a measure of diabetic instability.
F J Service, G D Molnar, J W Rosevear, E Ackerman, L C Gatewood, W F Taylor. Diabetes 1970
823
25



Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial--revisited.
John M Lachin, Saul Genuth, David M Nathan, Bernard Zinman, Brandy N Rutledge. Diabetes 2008
278
20

Glucose variability; does it matter?
Sarah E Siegelaar, Frits Holleman, Joost B L Hoekstra, J Hans DeVries. Endocr Rev 2010
271
20

Glucose fluctuations and activation of oxidative stress in patients with type 1 diabetes.
I M E Wentholt, W Kulik, R P J Michels, J B L Hoekstra, J H DeVries. Diabetologia 2008
139
20




Effects of prandial versus fasting glycemia on cardiovascular outcomes in type 2 diabetes: the HEART2D trial.
Itamar Raz, Peter W F Wilson, Krzysztof Strojek, Irina Kowalska, Velimir Bozikov, Anselm K Gitt, György Jermendy, Barbara N Campaigne, Lisa Kerr, Zvonko Milicevic,[...]. Diabetes Care 2009
230
17

A novel approach to continuous glucose analysis utilizing glycemic variation.
C M McDonnell, S M Donath, S I Vidmar, G A Werther, F J Cameron. Diabetes Technol Ther 2005
214
15

Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study.
M Muggeo, G Zoppini, E Bonora, E Brun, R C Bonadonna, P Moghetti, G Verlato. Diabetes Care 2000
189
14


Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes.
David M Nathan, Patricia A Cleary, Jye-Yu C Backlund, Saul M Genuth, John M Lachin, Trevor J Orchard, Philip Raskin, Bernard Zinman. N Engl J Med 2005
14


A1C variability predicts incident cardiovascular events, microalbuminuria, and overt diabetic nephropathy in patients with type 1 diabetes.
Johan Wadén, Carol Forsblom, Lena M Thorn, Daniel Gordin, Markku Saraheimo, Per-Henrik Groop. Diabetes 2009
142
13


Regulation of oxidative stress by glycaemic control: evidence for an independent inhibitory effect of insulin therapy.
L Monnier, C Colette, E Mas, F Michel, J P Cristol, C Boegner, D R Owens. Diabetologia 2010
100
12


Impact of glycemic and blood pressure variability on surrogate measures of cardiovascular outcomes in type 2 diabetic patients.
Alessandra Di Flaviani, Fabiana Picconi, Paola Di Stefano, Ilaria Giordani, Ilaria Malandrucco, Paola Maggio, Paola Palazzo, Fabrizio Sgreccia, Carlo Peraldo, Fabrizio Farina,[...]. Diabetes Care 2011
112
12

Should minimal blood glucose variability become the gold standard of glycemic control?
Irl B Hirsch, Michael Brownlee. J Diabetes Complications 2005
281
11

Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
Anushka Patel, Stephen MacMahon, John Chalmers, Bruce Neal, Laurent Billot, Mark Woodward, Michel Marre, Mark Cooper, Paul Glasziou, Diederick Grobbee,[...]. N Engl J Med 2008
11



Evaluation of a new measure of blood glucose variability in diabetes.
Boris P Kovatchev, Erik Otto, Daniel Cox, Linda Gonder-Frederick, William Clarke. Diabetes Care 2006
214
11

HbA(1c) variability and the development of microalbuminuria in type 2 diabetes: Tsukuba Kawai Diabetes Registry 2.
A Sugawara, K Kawai, S Motohashi, K Saito, S Kodama, Y Yachi, R Hirasawa, H Shimano, K Yamazaki, H Sone. Diabetologia 2012
66
16

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.
I M Stratton, A I Adler, H A Neil, D R Matthews, S E Manley, C A Cull, D Hadden, R C Turner, R R Holman. BMJ 2000
11


Fasting plasma glucose variability as a risk factor of retinopathy in Type 2 diabetic patients.
José A Gimeno-Orna, Francisco J Castro-Alonso, Beatriz Boned-Juliani, Luis M Lou-Arnal. J Diabetes Complications 2003
50
20




Association of glycemic variability and the presence and severity of coronary artery disease in patients with type 2 diabetes.
Gong Su, Shuhua Mi, Hong Tao, Zhao Li, Hongxia Yang, Hong Zheng, Yun Zhou, Changsheng Ma. Cardiovasc Diabetol 2011
153
10

Association of Glycemic Variability in Type 1 Diabetes With Progression of Microvascular Outcomes in the Diabetes Control and Complications Trial.
John M Lachin, Ionut Bebu, Richard M Bergenstal, Rodica Pop-Busui, F John Service, Bernard Zinman, David M Nathan. Diabetes Care 2017
78
12



Constant and intermittent high glucose enhances endothelial cell apoptosis through mitochondrial superoxide overproduction.
Ludovica Piconi, Lisa Quagliaro, Roberta Assaloni, Roberto Da Ros, Amabile Maier, Gianni Zuodar, Antonio Ceriello. Diabetes Metab Res Rev 2006
196
9


10-year follow-up of intensive glucose control in type 2 diabetes.
Rury R Holman, Sanjoy K Paul, M Angelyn Bethel, David R Matthews, H Andrew W Neil. N Engl J Med 2008
9

Assessment of the association between glycemic variability and diabetes-related complications in type 1 and type 2 diabetes.
J Smith-Palmer, M Brändle, R Trevisan, M Orsini Federici, S Liabat, W Valentine. Diabetes Res Clin Pract 2014
99
9

Is fasting glucose variability a risk factor for retinopathy in people with type 2 diabetes?
G Zoppini, G Verlato, G Targher, S Casati, E Gusson, V Biasi, F Perrone, E Bonora, M Muggeo. Nutr Metab Cardiovasc Dis 2009
31
25

Effects of intensive glucose lowering in type 2 diabetes.
Hertzel C Gerstein, Michael E Miller, Robert P Byington, David C Goff, J Thomas Bigger, John B Buse, William C Cushman, Saul Genuth, Faramarz Ismail-Beigi, Richard H Grimm,[...]. N Engl J Med 2008
8

THE M-VALVE, AN INDEX OF BLOOD-SUGAR CONTROL IN DIABETICS.
J SCHLICHTKRULL, O MUNCK, M JERSILD. Acta Med Scand 1965
375
8

Glycaemic variability is associated with coronary artery calcium in men with Type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes study.
J K Snell-Bergeon, R Roman, D Rodbard, S Garg, D M Maahs, I E Schauer, B C Bergman, G L Kinney, M Rewers. Diabet Med 2010
46
17


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.